Document:

NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM
REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD
PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH
A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

BARFRESH
FOOD GROUP Inc.

 

WARRANT
TO PURCHASE COMMON STOCK

 

	Warrant
    No. EN-____	Issuance
    Date: December 23, 2014 

 

Barfresh
Food Group Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, _________________, the registered holder hereof or its permitted
assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at
the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Common Stock (including any Warrants
to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Extension Warrant”),
at any time or times on or after the Issuance Date set forth above (“Issuance Date”), but not after 11:59 p.m.,
New York time, on the Expiration Date (as defined below), ____________________________ (subject to adjustment as provided
herein) fully paid and non-assessable shares of Common Stock (as defined below) (the “Extension Warrant Shares”).

 

This
Extension Warrant is issued pursuant to that certain promissory note payable to the initial Holder (“Note;”
all terms defined in the Note shall have the same meanings herein unless they are defined herein), warrant issued to the initial
Holder (“Original Warrant”) and a Registration Rights Agreement (“RRA”) entered into in
connection herewith.

 

    	 	 	 1

    	 

    

 

1.Exercise
of Extension Warrant.

 

(a)Mechanics
of Exercise. 

 

(i)Subject
to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(e)), the purchase
rights represented by this Extension Warrant are exercisable by the Holder in whole or in part at any time, or from time to time,
by the surrender of this Extension Warrant and the Notice of Exercise annexed hereto as Exhibit A duly completed and executed
on behalf of the Holder, at the office of the Company (or such other office or agency of the Company as it may designate by notice
in writing to the Holder at the address of the Holder appearing on the books of the Company), upon payment (i) in cash or by check
acceptable to the Company, or (ii) by cashless exercise as set forth in Section 1(c), below, of the purchase price of the shares
to be purchased.

 

(ii)This
Extension Warrant shall be deemed to have been exercised immediately prior to the close of business on the date of its surrender
for exercise as provided above and payment of the Exercise Price if exercised for cash, and the person entitled to receive the
shares of Common Stock issuable upon such exercise shall be treated for all purposes as the holder of record of such shares as
of the close of business on such date (the “Exercise Date”). As promptly as practicable on or after the Exercise
Date, but in no event more than three (3) business days thereafter (the “Warrant Share Delivery Date”), the
Company at its expense shall issue and deliver to the person or persons entitled to receive the same a certificate or certificates
for the number of shares issuable upon such exercise. In the event that this Extension Warrant is exercised in part, the Company
at its expense will execute and deliver a new Extension Warrant of like tenor exercisable for the number of shares for which this
Extension Warrant may then be exercised.

 

(iii)The
Holder, at its option, may exercise this Extension Warrant in a cashless exercise transaction pursuant to this subsection (c)
(a “Cashless Exercise”). In order to effect a Cashless Exercise, the Holder shall surrender this Extension Warrant
at the principal office of the Company together with an Exercise Form, completed and executed, indicating Holder’s election
to effect a Cashless Exercise, in which event the Company shall issue Holder a number of shares of Common Stock computed using
the following formula:

 

X
= Y (A-B)/A

 

where:
X = the number of shares of Common Stock to be issued to Holder.

 

Y
= the number of shares of Common Stock for which this Extension Warrant is being Exercised.

 

    	 	 	 2

    	 

    

 

A
= the Market Price of one (1) share of Common Stock (for purposes of this Section 1(c), where “Market Price,” means
the Volume Weighted Average Price (as defined herein) of one (1) share of Common Stock during the ten (10) consecutive Trading
Day period immediately preceding the Exercise Date.

 

B
= the Exercise Price.

 

As
used herein, the “Volume Weighted Average Price” for any security as of any date means the volume weighted average
sale price on The NASDAQ Global Market (“NASDAQ”) as reported by, or based upon data reported by, Bloomberg Financial
Markets or an equivalent, reliable reporting service mutually acceptable to and hereafter designated by holders of a majority
in interest of the Extension Warrants and the Company (“Bloomberg”) or, if NASDAQ is not the principal trading market
for such security, the volume weighted average sale price of such security on the principal securities exchange or trading market
where such security is listed or traded as reported by Bloomberg, or, if no volume weighted average sale price is reported for
such security, then the average of the last closing trade price of such security over the ten trading days prior to the Exercise
Date, with such closing trade prices as reported by Bloomberg. If the Volume Weighted Average Price cannot be calculated for such
security on such date in the manner provided above, the volume weighted average price shall be the fair market value as determined
in good faith by the Company’s Board of Directors. “Trading Day” shall mean any day on which the Common Stock
is traded for any period on NASDAQ, or on the principal securities exchange or other securities market on which the Common Stock
is then being traded.

 

For
purposes of Rule 144 and sub-section (d)(3)(ii) thereof, it is intended, understood and acknowledged that the Common Stock issued
upon Exercise of this Extension Warrant in a Cashless Exercise transaction shall be deemed to have been acquired at the time this
Extension Warrant was issued. Moreover, it is intended, understood and acknowledged that the holding period for the Common Stock
issued upon Exercise of this Extension Warrant in a Cashless Exercise transaction shall be deemed to have commenced on the date
this Extension Warrant was issued.

 

In
the case of a dispute as to the determination of the closing price or the Volume Weighted Average Price of the Company’s
Common Stock or the arithmetic calculation of the Exercise Price or Market Price, the Company shall submit the disputed determinations
or arithmetic calculations via facsimile or email within four (4) business days of receipt, or deemed receipt, of the Exercise
Notice, or other event giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable
to agree upon such determination or calculation within two (2) business days of such disputed determination or arithmetic calculation
being submitted to the Holder, then the Company shall, within two (2) business days submit via facsimile or email (i) the disputed
determination of the closing price or the Volume Weighted Average Price of the Company’s Common Stock to an independent,
reputable investment bank selected by the Company and approved by the Holder, which approval shall not be unreasonably withheld
or delayed or (ii) the disputed arithmetic calculation of the Exercise Price, Market Price to the Company’s independent,
outside accountant, or another accounting firm of national standing selected by the Company. The Company shall cause the investment
bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder
of the results no later than the later of (i) five (5) business days from the time it receives the disputed determinations or
calculations or (ii) five (5) business days from the selection of the investment bank and accounting firm, as applicable. Such
investment bank’s or accountant’s determination or calculation, as the case may be, shall be binding upon all parties
absent demonstrable error.

 

    	 	 	 3

    	 

    

 

(b)Exercise
Price. For purposes of this Extension Warrant, “Exercise Price” means $0.485, subject to adjustment as provided
herein.

 

(c)Company’s
Failure to Timely Deliver Securities. If the Company shall fail, for any reason or for no reason, to issue to the Holder within
the later of (i) three (3) Trading Days after receipt of the applicable Exercise Notice (or four (4) Trading Days if the Exercise
Notice is delivered after 5:00 P.M., New York City time, on the Exercise Date) and (ii) two (2) Trading Days after the Company’s
receipt of the Aggregate Exercise Price (or three (3) Trading Days if the Company receives the Aggregate Exercise Price after
5:00 P.M., New York City time, on the Exercise Date) (such later date, the “Share Delivery Deadline”), a certificate
for the number of shares of Common Stock to which the Holder is entitled and register such shares of Common Stock on the Company’s
share register or to credit the Holder’s balance account with DTC for such number of shares of Common Stock to which the
Holder is entitled upon the Holder’s exercise of this Extension Warrant (as the case may be), and if after such Share Delivery
Deadline the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of
a sale by the Holder of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common
Stock equal to all or any portion of the number of shares of Common Stock, issuable upon such exercise that the Holder so anticipated
receiving from the Company, then, in addition to all other remedies available to the Holder, the Company shall, within three (3)
Business Days after the Holder’s request and in the Holder’s discretion, either (i) pay cash to the Holder in an amount
equal to the Holder’s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for
the shares of Common Stock so purchased (including, without limitation, by any other Person in respect, or on behalf, of the Holder)
(the “Buy-In Price”), at which point the Company’s obligation to so issue and deliver such certificate
or credit the Holder’s balance account with DTC for the number of shares of Common Stock to which the Holder is entitled
upon the Holder’s exercise hereunder (as the case may be) (and to issue such shares of Common Stock) shall terminate, or
(ii) promptly honor its obligation to so issue and deliver to the Holder a certificate or certificates representing such shares
of Common Stock or credit the Holder’s balance account with DTC for the number of shares of Common Stock to which the Holder
is entitled upon the Holder’s exercise hereunder (as the case may be) and pay cash to the Holder in an amount equal to the
excess (if any) of the Buy-In Price over the product of (A) such number of shares of Common Stock multiplied by (B) the lowest
Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the date of the applicable Exercise
Notice and ending on the date of such issuance and payment under this clause (ii).

 

    	 	 	 4

    	 

    

 

(d)Disputes.
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Extension
Warrant Shares to be issued pursuant to the terms hereof, the Company shall promptly issue to the Holder the number of Extension
Warrant Shares that are not disputed and resolve such dispute in accordance with Section 12.

 

(e)Limitations
on Exercises. Notwithstanding anything to the contrary contained in this Extension Warrant, this Extension Warrant shall not be
exercisable by the Holder hereof to the extent (but only to the extent) that the Holder together with any of its affiliates would
beneficially own in excess of 9.99% (the “Maximum Percentage”) of the Common Stock after giving effect to such
exercise and as a result of such exercise, unless Holder and its affiliates beneficially own in excess of Maximum Percentage prior
to the issuance of this Extension Warrant. To the extent the above limitation applies, the determination of whether this Extension
Warrant shall be exercisable (vis-à-vis other convertible, exercisable or exchangeable securities owned by the Holder or
any of its affiliates) and of which such securities shall be exercisable (as among all such securities owned by the Holder) shall,
subject to such Maximum Percentage limitation, be determined on the basis of the first submission to the Company for conversion,
exercise or exchange (as the case may be). No prior inability to exercise this Extension Warrant pursuant to this paragraph shall
have any effect on the applicability of the provisions of this paragraph with respect to any subsequent determination of exercisability.
For the purposes of this paragraph, beneficial ownership and all determinations and calculations (including, without limitation,
with respect to calculations of percentage ownership) shall be determined in accordance with Section 13(d) of the Exchange Act
and the rules and regulations promulgated thereunder. The provisions of this paragraph shall be implemented in a manner otherwise
than in strict conformity with the terms of this paragraph to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended Maximum Percentage beneficial ownership limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such Maximum Percentage limitation. The limitations contained in this paragraph
shall apply to a successor Holder of this Extension Warrant. For any reason at any time, upon the written or oral request of the
Holder, the Company shall within one (1) Business Day confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding, including by virtue of any prior conversion or exercise of convertible or exercisable securities into
Common Stock, including, without limitation, pursuant to this Extension Warrant. By written notice to the Company, any Holder
may increase or decrease the Maximum Percentage to any other percentage specified in such notice; provided that (i) any such increase
will not be effective until the 61st day after such notice is delivered to the Company, and (ii) any such increase or decrease
will apply only to the Holder sending such notice and not to any other holder of the Extension Warrants. At any time when this
Extension Warrant, in its entirety or a portion thereof, is not exercisable by Holder in accordance with the Maximum Percentage
limitation described above, Holder may not assign or otherwise transfer this Extension Warrant in its entirety (in the event that
the entirety of the Extension Warrant is not exercisable as described) or the portion of this Extension Warrant that is not exercisable
as described (in the event that a portion of this Extension Warrant is not exercisable as described).

 

    	 	 	 5

    	 

    

 

(f)Insufficient
Authorized Shares. The Company shall at all times keep reserved for issuance under this Extension Warrant a number of shares of
Common Stock as shall be necessary to satisfy the Company’s obligation to issue shares of Common Stock hereunder (without
regard to any limitation otherwise contained herein with respect to the number of shares of Common Stock that may be acquirable
upon exercise of this Extension Warrant). If, notwithstanding the foregoing, and not in limitation thereof, at any time while
any of the Extension Warrants remain outstanding the Company does not have a sufficient number of authorized and unreserved shares
of Common Stock to satisfy its obligation to reserve for issuance upon exercise of the Extension Warrants at least a number of
shares of Common Stock equal to the number of shares of Common Stock as shall from time to time be necessary to effect the exercise
of all of the Extension Warrants then outstanding (the “Required Reserve Amount”) (an “Authorized
Share Failure”), then the Company shall promptly take all action necessary to increase the Company’s authorized
shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount for all the Extension
Warrants then outstanding. Without limiting the generality of the foregoing sentence, as soon as practicable after the date of
the occurrence of an Authorized Share Failure, but in no event later than ninety (90) days after the occurrence of such Authorized
Share Failure, the Company shall hold a meeting of its stockholders for the approval of an increase in the number of authorized
shares of Common Stock. In connection with such meeting, the Company shall provide each stockholder with a proxy statement or
information statement and shall use its commercially reasonable efforts to solicit its stockholders’ approval of such increase
in authorized shares of Common Stock and to cause its board of directors to recommend to the stockholders that they approve such
proposal.

 

Adjustment
of Exercise Price and Number of Extension Warrant Shares. (a)If the Company, at any time on or after the Issuance Date,
(i) pays a stock dividend on one or more classes of its then outstanding shares of Common Stock or otherwise makes a distribution
on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides (by any stock split, stock dividend,
recapitalization or otherwise) one or more classes of its then outstanding shares of Common Stock into a larger number of shares
or (iii) combines (by combination, reverse stock split or otherwise) one or more classes of its then outstanding shares of Common
Stock into a smaller number of shares, then in each such case the Exercise Price shall be multiplied by a fraction (the “Adjustment
Metric”) of which the numerator shall be the number of shares of Common Stock outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event and the number
of Extension Warrant Shares shall be divided by the Adjustment Metric. Any adjustment made pursuant to clause (i) of this paragraph
shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend
or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after
the effective date of such subdivision or combination. If any event requiring an adjustment under this paragraph occurs during
the period that an Exercise Price is calculated hereunder, then the calculation of such Exercise Price shall be adjusted appropriately
to reflect such event.

 

    	 	 	 6

    	 

    

 

2.Noncircumvention.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws or
through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities,
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Extension Warrant,
and will at all times in good faith carry out all the provisions of this Extension Warrant and take all action as may be required
to protect the rights of the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the
par value of any shares of Common Stock receivable upon the exercise of this Extension Warrant above the Exercise Price then in
effect, (ii) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally
issue fully paid and non-assessable shares of Common Stock upon the exercise of this Extension Warrant, and (iii) shall, so long
as any of the Extension Warrants are outstanding, take all action necessary to reserve and keep available out of its authorized
and unissued shares of Common Stock, solely for the purpose of effecting the exercise of the Extension Warrants, the maximum number
of shares of Common Stock as shall from time to time be necessary to effect the exercise of the Extension Warrants then outstanding
(without regard to any limitations on exercise).

 

3.Holder
Not Deemed a Stockholder. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder
of this Extension Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the
Company for any purpose, nor shall anything contained in this Extension Warrant be construed to confer upon the Holder, solely
in its capacity as the Holder of this Extension Warrant, any of the rights of a stockholder of the Company or any right to vote,
give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation,
merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to
the issuance to the Holder of the Extension Warrant Shares which it is then entitled to receive upon the due exercise of this
Extension Warrant. In addition, nothing contained in this Extension Warrant shall be construed as imposing any liabilities on
the Holder to purchase any securities (upon exercise of this Extension Warrant or otherwise) or as a stockholder of the Company,
whether such liabilities are asserted by the Company or by creditors of the Company.

 

4.Reissuance
of Extension Warrants.

 

(a)Transfer
of Extension Warrant. If this Extension Warrant is to be transferred, the Holder shall surrender this Extension Warrant to the
Company, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Extension Warrant (in accordance
with Section 5(d)), registered as the Holder may request, representing the right to purchase the number of Extension Warrant Shares
being transferred by the Holder and, if less than the total number of Extension Warrant Shares then underlying this Extension
Warrant is being transferred, a new Extension Warrant (in accordance with Section 5(d)) to the Holder representing the right to
purchase the number of Extension Warrant Shares not being transferred.

 

    	 	 	 7

    	 

    

 

(b)Lost,
Stolen or Mutilated Extension Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss,
theft, destruction or mutilation of this Extension Warrant (as to which a written certification and the indemnification contemplated
below shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking by the
Holder to the Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation of this
Extension Warrant, the Company shall execute and deliver to the Holder a new Extension Warrant (in accordance with Section 5(d))
representing the right to purchase the Extension Warrant Shares then underlying this Extension Warrant.

 

(c)Exchangeable
for Multiple Extension Warrants. This Extension Warrant is exchangeable, upon the surrender hereof by the Holder at the principal
office of the Company, for a new Extension Warrant or Extension Warrants (in accordance with Section 5(d)) representing in the
aggregate the right to purchase the number of Extension Warrant Shares then underlying this Extension Warrant, and each such new
Extension Warrant will represent the right to purchase such portion of such Extension Warrant Shares as is designated by the Holder
at the time of such surrender; provided, however, no warrants for fractional shares of Common Stock shall be given.

 

(d)Issuance
of New Extension Warrants. Whenever the Company is required to issue a new Extension Warrant pursuant to the terms of this Extension
Warrant, such new Extension Warrant (i) shall be of like tenor with this Extension Warrant, (ii) shall represent, as indicated
on the face of such new Extension Warrant, the right to purchase the Extension Warrant Shares then underlying this Extension Warrant
(or in the case of a new Extension Warrant being issued pursuant to Section 5(a) or Section 5(c), the Extension Warrant Shares
designated by the Holder which, when added to the number of shares of Common Stock underlying the other new Extension Warrants
issued in connection with such issuance, does not exceed the number of Extension Warrant Shares then underlying this Extension
Warrant), (iii) shall have an issuance date, as indicated on the face of such new Extension Warrant which is the same as the Issuance
Date, and (iv) shall have the same rights and conditions as this Extension Warrant.

 

5.Registration
Rights. The Holder is entitled to the benefit of certain registration rights with respect to the Extension Warrant Shares,
pursuant to the RRA. The Company shall prepare and, as soon as practicable, but in no event later than the Filing Deadline, file
with the SEC the Registration Statement on such applicable form covering the resale of all of the Registrable Securities (subject
to any cutbacks based on Rule 415 of the 1933 Securities Act). The Company shall use its commercially reasonable best efforts
to have such Registration Statement declared effective by the SEC as soon as practicable, but in no event later than the applicable
Effectiveness Date for such Registration Statement.

 

    	 	 	 8

    	 

    

 

6.Notices.
Whenever notice is required to be given under this Extension Warrant, unless otherwise provided herein, such notice shall be given
in accordance with the RRA. The Company shall provide the Holder with prompt written notice of all actions taken pursuant to this
Extension Warrant, including in reasonable detail a description of such action and the reason therefor.

 

7.Amendment
and Waiver. Any terms of the Extension Warrants may be amended, modified or waived with, but only with, the written consent
of the Company and the Majority Holders (as defined in the Notes); provided, however, that no such waiver, amendment
or modification will reduce the aforesaid percentage in interest of the Notes the Holders of which are required to consent to
any waiver, amendment or modification; provided, further, that in the event that such waiver, amendment or modification
adversely affects the rights or obligations of a Holder in a different manner than the other Holders, such waiver, amendment or
modification shall also require the written consent of such differently affected Holder. Any amendment or waiver effected in accordance
with this Section will be binding upon the Company, the Holders and each transferee of the Extension Warrants.

 

8.Severability.
If any provision of this Extension Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court
of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended
to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision
shall not affect the validity of the remaining provisions of this Extension Warrant so long as this Extension Warrant as so modified
continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the
prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective
expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred
upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s)
with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable
provision(s).

 

9.Governing
Law. This Extension Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning
the construction, validity, interpretation and performance of this Extension Warrant shall be governed by, the internal laws of
the State of Delaware without giving effect to any choice of law or conflict of law provision or rule (whether of the State of
Delaware or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of
Delaware. Each of the Parties submits to the jurisdiction of any state or federal court sitting in the State of Delaware, in any
action or proceeding arising out of or relating to this Agreement and agrees that all claims in respect of the action or proceeding
may be heard and determined in any such court. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any manner permitted by law. Nothing contained herein shall be deemed or operate to preclude the Holder from bringing
suit or taking other legal action against the Company in any other jurisdiction to collect on the Company’s obligations
to the Holder or to enforce a judgment or other court ruling in favor of the Holder. THE COMPANY HEREBY IRREVOCABLY WAIVES ANY
RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH
OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

    	 	 	 9

    	 

    

 

10.Construction;
Headings. This Extension Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed
against any Person as the drafter hereof. The headings of this Extension Warrant are for convenience of reference and shall not
form part of, or affect the interpretation of, this Extension Warrant.

 

11.Dispute
Resolution. In the case of a dispute as to the determination of the Exercise Price, the Closing Sale Price, the Bid Price
or fair market value or the arithmetic calculation of the Extension Warrant Shares (as the case may be), the Company or the Holder
(as the case may be) shall submit the disputed determinations or arithmetic calculations (as the case may be) via facsimile or
email (i) within two (2) Business Days after receipt of the applicable notice giving rise to such dispute to the Company or the
Holder (as the case may be) or (ii) if no notice gave rise to such dispute, at any time after the Holder learned of the circumstances
giving rise to such dispute. If the Holder and the Company are unable to agree upon such determination or calculation (as the
case may be) of the Exercise Price, the Closing Sale Price, the Bid Price or fair market value or the number of Extension Warrant
Shares (as the case may be) within three (3) Business Days of such disputed determination or arithmetic calculation being submitted
to the Company or the Holder (as the case may be), then the Company shall, within two (2) Business Days submit via facsimile or
email (a) the disputed determination of the Exercise Price, the Closing Sale Price, the Bid Price or fair market value (as the
case may be) to an independent, reputable investment bank selected by the Holder or (b) the disputed arithmetic calculation of
the Extension Warrant Shares to the Company’s independent, outside accountant. The Company shall cause at its expense the
investment bank or the accountant (as the case may be) to perform the determinations or calculations (as the case may be) and
notify the Company and the Holder of the results no later than ten (10) Business Days from the time it receives such disputed
determinations or calculations (as the case may be). Such investment bank’s or accountant’s determination or calculation
(as the case may be) shall be binding upon all parties absent demonstrable error. With regard to any conflict of methods for dispute
resolution as described in this paragraph compared to methods described in 1(a)(iii) above, the latter shall prevail and be the
applicable method in that circumstance.

 

    	 	 	 10

    	 

    

 

12.Remedies,
Characterization, Other Obligations, Breaches and Injunctive Relief. The remedies provided in this Extension Warrant shall
be cumulative and in addition to all other remedies available under this Extension Warrant, the Original Warrants, the Notes and
the RRA, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall
limit the right of the Holder to pursue actual damages for any failure by the Company to comply with the terms of this Extension
Warrant. The Company covenants to the Holder that there shall be no characterization concerning this instrument other than as
expressly provided herein. Amounts set forth or provided for herein with respect to payments, exercises and the like (and the
computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided herein, be
subject to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach by it of its
obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate.
The Company therefore agrees that, in the event of any such breach or threatened breach, the holder of this Extension Warrant
shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, without the necessity
of showing economic loss and without any bond or other security being required. The Company shall provide all information and
documentation to the Holder that is requested by the Holder to enable the Holder to confirm the Company’s compliance with
the terms and conditions of this Extension Warrant (including, without limitation, compliance with Section 2 hereof). The
issuance of shares and certificates for shares as contemplated hereby upon the exercise of this Extension Warrant shall be made
without charge to the Holder or such shares for any issuance tax or other costs in respect thereof, provided that the Company
shall not be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of
any certificate in a name other than the Holder or its agent on its behalf.

 

13.Transfer.
Neither the issuance and sale of the securities represented by this certificate nor the securities into which these securities
are exercisable have been registered under the Securities Act of 1933, as amended, or applicable state securities laws. The securities
may not be offered for sale, sold, transferred or assigned (i) in the absence of (a) an effective registration statement for the
securities under the Securities Act of 1933, as amended, or (b) an opinion of counsel to the Holder (if requested by the Company),
in a form reasonably acceptable to the Company, that registration is not required under said Act or (ii) unless sold or eligible
to be sold pursuant to Rule 144 or Rule 144a under said Act. Notwithstanding the foregoing, the securities may be pledged in connection
with a bona fide margin account or other loan or financing arrangement secured by the securities.

 

14.Certain
Definitions. For purposes of this Extension Warrant, the following terms shall have the following meanings:

 

(a)“Common
Stock” means the common stock, $0.000001 par value per share, of the Company.

 

(b)
“Convertible Securities” means
any stock or other security (other than Options) that is at any time and under any circumstances, directly or indirectly, convertible
into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares of Common Stock.

 

    	 	 	 11

    	 

    

 

(c)“Expiration
Date” means December 20, 2017, or, if such date falls on a day other than a Business Day or on which trading does not
take place on the Principal Market (a “Holiday”), the next date that is not a Holiday.

 

(d)“Options”
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.

 

(e)
“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a
trust, an unincorporated organization, any other entity or a government or any department or agency thereof.

 

 (f) “Principal Market” means the OTC Bulletin Board.

 

 (g) “Trading Day” means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded, provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the Holder.

 

[Signature
Page Follows]

 

    	 	 	 12

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the Issuance Date set out above.

 

	 	BARFRESH
    FOOD GROUP Inc.
	 	 	 
	 	By:	 
	 	Name:	Arnold
    Tinter
	 	Title:	Chief
    Financial Officer

 

    	 

    	 

    

 

EXHIBIT
A

 

EXERCISE
NOTICE

 

BARFRESH
FOOD GROUP Inc.

 

The
undersigned holder hereby exercises the right to purchase _________________ of the shares of Common Stock (“Warrant Shares”)
of Barfresh Food Group Inc., a Delaware corporation (the “Company”), evidenced by Warrant to Purchase Common
Stock No. _______ (the “Warrant”). Capitalized terms used herein and not otherwise defined shall have the respective
meanings set forth in the Warrant.

 

1.Payment
of Exercise Price. The Holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in
accordance with the terms of the Warrant.

 

2.Delivery
of Warrant Shares. The Company shall deliver to Holder, or its designee or agent as specified below, __________ Warrant Shares
in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, to the following address:

 

	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

	Date:	 	 	 
	 	 	 	 
	 	 	 	Registered
    Holder

 

	 	By:	 
	 	Name:	 
	 	Title:	 

 

    	 

    	 

    

 

EXHIBIT
B

 

ACKNOWLEDGMENT

 

The
Company hereby acknowledges this Exercise Notice and hereby directs ______________ to issue the above indicated number of shares
of Common Stock in accordance with the Transfer Agent Instructions dated ______________, from the Company and acknowledged and
agreed to by _______________.

 

	Date: __________________	BARFRESH FOOD GROUP Inc.
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM
REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD
PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH
A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

BARFRESH
FOOD GROUP Inc.

 

WARRANT
TO PURCHASE COMMON STOCK

 

	Warrant
    No.: H-[___________]	 	Issuance
    Date: _______________, 2015 

 

Barfresh
Food Group Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, [___________], the registered holder hereof or its permitted assigns
(the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price
(as defined below) then in effect, upon exercise of this Warrant to Purchase Common Stock (including any Warrants to Purchase
Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after
the Issuance Date set forth above (“Issuance Date”), but not after 11:59 p.m., New York time, on the Expiration Date
(as defined below), [___________](_________) (subject to adjustment as provided herein) fully paid and non-assessable shares of
Common Stock (as defined below) (the “Warrant Shares”). This Warrant is one of a series of warrants designated as
“Series H Warrants” issued pursuant to that certain Securities Purchase Agreement by and between the Company and purchasers
signatory thereto (“Purchase Agreement”). Capitalized terms not defined herein have the meanings ascribed to them
in the Purchase Agreement.

 

1. Exercise
of Warrant.

 

(a) Mechanics
of Exercise. 

 

(i) Subject
to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(e)), the purchase
rights represented by this Warrant are exercisable by the Holder in whole or in part at any time, or from time to time, by the
surrender of this Warrant and the Notice of Exercise annexed hereto as Exhibit A duly completed and executed on behalf
of the Holder, at the office of the Company (or such other office or agency of the Company as it may designate by notice in writing
to the Holder at the address of the Holder appearing on the books of the Company), upon payment in cash or by check acceptable
to the Company of the purchase price of the shares to be purchased.

 

(ii) This
Warrant shall be deemed to have been exercised immediately prior to the close of business on the date of its surrender for exercise
as provided above and payment of the Exercise Price if exercised for cash, and the person entitled to receive the shares of Common
Stock issuable upon such exercise shall be treated for all purposes as the holder of record of such shares as of the close of
business on such date (the “Exercise Date”). As promptly as practicable on or after the Exercise Date, but in no event
more than three (3) business days thereafter (the “Warrant Share Delivery Date”), the Company at its expense shall
issue and deliver to the person or persons entitled to receive the same a certificate or certificates for the number of shares
issuable upon such exercise. In the event that this Warrant is exercised in part, the Company at its expense will execute and
deliver a new Warrant of like tenor exercisable for the number of shares for which this Warrant may then be exercised.

 

    	 

    	 

    

 

(b) Exercise
Price. For purposes of this Warrant, “Exercise Price” means $1.00, subject to adjustment as provided herein.

 

(c) Company’s
Failure to Timely Deliver Securities. If the Company shall fail, for any reason or for no reason, to issue to the Holder within
the later of (i) three (3) Trading Days after receipt of the applicable Exercise Notice (or four (4) Trading Days if the Exercise
Notice is delivered after 5:00 P.M., New York City time, on the Exercise Date) and (ii) two (2) Trading Days after the Company’s
receipt of the Aggregate Exercise Price (or three (3) Trading Days if the Company receives the Aggregate Exercise Price after
5:00 P.M., New York City time, on the Exercise Date) (such later date, the “Share Delivery Deadline”), a certificate
for the number of shares of Common Stock to which the Holder is entitled and register such shares of Common Stock on the Company’s
share register or to credit the Holder’s balance account with DTC for such number of shares of Common Stock to which the
Holder is entitled upon the Holder’s exercise of this Warrant (as the case may be), and if after such Share Delivery Deadline
the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale
by the Holder of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal
to all or any portion of the number of shares of Common Stock, issuable upon such exercise that the Holder so anticipated receiving
from the Company, then, in addition to all other remedies available to the Holder, the Company shall, within three (3) Business
Days after the Holder’s request and in the Holder’s discretion, either (i) pay cash to the Holder in an amount equal
to the Holder’s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the
shares of Common Stock so purchased (including, without limitation, by any other Person in respect, or on behalf, of the Holder)
(the “Buy-In Price”), at which point the Company’s obligation to so issue and deliver such certificate or credit
the Holder’s balance account with DTC for the number of shares of Common Stock to which the Holder is entitled upon the
Holder’s exercise hereunder (as the case may be) (and to issue such shares of Common Stock) shall terminate, or (ii) promptly
honor its obligation to so issue and deliver to the Holder a certificate or certificates representing such shares of Common Stock
or credit the Holder’s balance account with DTC for the number of shares of Common Stock to which the Holder is entitled
upon the Holder’s exercise hereunder (as the case may be) and pay cash to the Holder in an amount equal to the excess (if
any) of the Buy-In Price over the product of (A) such number of shares of Common Stock multiplied by (B) the lowest Closing Sale
Price of the Common Stock on any Trading Day during the period commencing on the date of the applicable Exercise Notice and ending
on the date of such issuance and payment under this clause (ii).

 

(d) Disputes.
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant
Shares to be issued pursuant to the terms hereof, the Company shall promptly issue to the Holder the number of Warrant Shares
that are not disputed and resolve such dispute in accordance with Section 12.

 

    	 

    	 

    

 

(e) Limitations
on Exercises. Notwithstanding anything to the contrary contained in this Warrant, this Warrant shall not be exercisable by
the Holder hereof to the extent (but only to the extent) that the Holder together with any of its affiliates would beneficially
own in excess of 9.99% (the “Maximum Percentage”) of the Common Stock after giving effect to such exercise and as
a result of such exercise. To the extent the above limitation applies, the determination of whether this Warrant shall be exercisable
(vis-à-vis other convertible, exercisable or exchangeable securities owned by the Holder or any of its affiliates) and
of which such securities shall be exercisable (as among all such securities owned by the Holder) shall, subject to such Maximum
Percentage limitation, be determined on the basis of the first submission to the Company for conversion, exercise or exchange
(as the case may be). No prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability
of the provisions of this paragraph with respect to any subsequent determination of exercisability. For the purposes of this paragraph,
beneficial ownership and all determinations and calculations (including, without limitation, with respect to calculations of percentage
ownership) shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. The provisions of this paragraph shall be implemented in a manner otherwise than in strict conformity with the terms
of this paragraph to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Maximum
Percentage beneficial ownership limitation herein contained or to make changes or supplements necessary or desirable to properly
give effect to such Maximum Percentage limitation. The limitations contained in this paragraph shall apply to a successor Holder
of this Warrant. For any reason at any time, upon the written or oral request of the Holder, the Company shall within one (1)
Business Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding, including by virtue
of any prior conversion or exercise of convertible or exercisable securities into Common Stock, including, without limitation,
pursuant to this Warrant. By written notice to the Company, any Holder may increase or decrease the Maximum Percentage to any
other percentage specified in such notice; provided that (i) any such increase will not be effective until the 61st day after
such notice is delivered to the Company, and (ii) any such increase or decrease will apply only to the Holder sending such notice
and not to any other holder of the Warrants. At any time when this Warrant, in its entirety or a portion thereof, is not exercisable
by Holder in accordance with the Maximum Percentage limitation described above, Holder may not assign or otherwise transfer this
Warrant in its entirety (in the event that the entirety of the Warrant is not exercisable as described) or the portion of this
Warrant that is not exercisable as described (in the event that a portion of this Warrant is not exercisable as described).

 

(f) Insufficient
Authorized Shares. The Company shall at all times keep reserved for issuance under this Warrant a number of shares of Common
Stock as shall be necessary to satisfy the Company’s obligation to issue shares of Common Stock hereunder (without regard
to any limitation otherwise contained herein with respect to the number of shares of Common Stock that may be acquirable upon
exercise of this Warrant). If, notwithstanding the foregoing, and not in limitation thereof, at any time while any of the Warrants
remain outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy
its obligation to reserve for issuance upon exercise of the Warrants at least a number of shares of Common Stock equal to the
number of shares of Common Stock as shall from time to time be necessary to effect the exercise of all of the Warrants then outstanding
(the “Required Reserve Amount”) (an “Authorized Share Failure”), then the Company shall promptly take
all action necessary to increase the Company’s authorized shares of Common Stock to an amount sufficient to allow the Company
to reserve the Required Reserve Amount for all the Warrants then outstanding. Without limiting the generality of the foregoing
sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later than ninety
(90) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its stockholders for the
approval of an increase in the number of authorized shares of Common Stock. In connection with such meeting, the Company shall
provide each stockholder with a proxy statement or information statement and shall use its commercially reasonable efforts to
solicit its stockholders’ approval of such increase in authorized shares of Common Stock and to cause its board of directors
to recommend to the stockholders that they approve such proposal.

 

    	 

    	 

    

 

(g) Adjustment
of Exercise Price and Number of Warrant Shares. If the Company, at any time on or after the Issuance Date, (i) pays a stock
dividend on one or more classes of its then outstanding shares of Common Stock or otherwise makes a distribution on any class
of capital stock that is payable in shares of Common Stock, (ii) subdivides (by any stock split, stock dividend, recapitalization
or otherwise) one or more classes of its then outstanding shares of Common Stock into a larger number of shares or (iii) combines
(by combination, reverse stock split or otherwise) one or more classes of its then outstanding shares of Common Stock into a smaller
number of shares, then in each such case the Exercise Price shall be multiplied by a fraction (the “Adjustment Metric”)
of which the numerator shall be the number of shares of Common Stock outstanding immediately before such event and of which the
denominator shall be the number of shares of Common Stock outstanding immediately after such event and the number of Warrant Shares
shall be divided by the Adjustment Metric. Any adjustment made pursuant to clause (i) of this paragraph shall become effective
immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution, and
any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date
of such subdivision or combination. If any event requiring an adjustment under this paragraph occurs during the period that an
Exercise Price is calculated hereunder, then the calculation of such Exercise Price shall be adjusted appropriately to reflect
such event.

 

2. Noncircumvention.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws or
through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities,
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will
at all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the
rights of the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any
shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all
such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable
shares of Common Stock upon the exercise of this Warrant, and (iii) shall, so long as any of the Warrants are outstanding, take
all action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose
of effecting the exercise of the Warrants, the maximum number of shares of Common Stock as shall from time to time be necessary
to effect the exercise of the Warrants then outstanding (without regard to any limitations on exercise).

 

3. Holder
Not Deemed a Stockholder. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder
of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for
any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the
Holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any
corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or
otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder
of the Warrant Shares which it is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained
in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this
Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors
of the Company.

 

4. Reissuance
of Warrants.

 

(a) Transfer
of Warrant. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company
will forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 5(d)), registered as the
Holder may request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less
than the total number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section
5(d)) to the Holder representing the right to purchase the number of Warrant Shares not being transferred.

 

    	 

    	 

    

 

(b) Lost,
Stolen or Mutilated Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant (as to which a written certification and the indemnification contemplated below shall
suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to
the Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation of this Warrant,
the Company shall execute and deliver to the Holder a new Warrant (in accordance with Section 5(d)) representing the right to
purchase the Warrant Shares then underlying this Warrant.

 

(c) Exchangeable
for Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the
Company, for a new Warrant or Warrants (in accordance with Section 5(d)) representing in the aggregate the right to purchase the
number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion
of such Warrant Shares as is designated by the Holder at the time of such surrender; provided, however, no warrants for fractional
shares of Common Stock shall be given.

 

(d) Issuance
of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant
(i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to
purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 5(a)
or Section 5(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying
the other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this
Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date,
and (iv) shall have the same rights and conditions as this Warrant.

 

5. Redemption.

 

(a) Provided
the Warrant Shares are subject to an effective registration statement, the Warrants may be redeemed, at the option of the Company,
at a redemption price of $0.001 per Warrant Share, provided (i) the Market Price of the Common Stock receivable upon exercise
of the Warrant will be at least $1.50 per share (the “Target Price”), subject to adjustment as set otherwise provided
herein and (2) and the Common Stock has average volume during that period of at least 100,000 shares per day. “Market price”
for the purpose of this Section 5 means the closing bid prices for any twenty (20) of thirty (30) consecutive trading days, ending
on the third day prior to the date of the notice of redemption of the Common Stock (“Notice of Redemption Date”).

 

(b) In
the event the conditions set forth herein are met, and the Company will desire to exercise its right so to redeem the Warrants,
it will mail a notice of redemption to the holders of the Warrants to be redeemed, first class, postage prepaid, not later than
the twentieth day before the date fixed for redemption, at its last address as will appear on the records of the Company. Any
notice mailed in the manner provided here will be conclusively presumed to have been duly given whether or not the holder receives
such notice. The notice of redemption will specify the (i) redemption price, (ii) the date fixed for redemption, (iii) the place
where the Warrant Certificates will be delivered and the redemption price paid, and (iv) that the right to exercise the Warrant
will terminate at 5:00 p.m. (New York time) on the business day immediately proceeding the date fixed for redemption. The date
fixed for redemption of the Warrants will be the Redemption Date. No failure to mail such notice nor any defect in such notice
or in its mailing will affect the validity of the proceedings for such redemption except as to a holder (a) to whom notice was
not mailed; or (b) whose notice was defective.

 

    	 

    	 

    

 

(c) An
affidavit of the Secretary or an Assistant Secretary of the Company that notice of redemption has been mailed will, in the absence
of fraud, be prima facie evidence of the facts stated in such affidavit. Except as here provided here, any right to exercise a
Warrant will terminate at 5:00 p.m. (New York time) on the business day immediately proceeding the Redemption Date. On and after
the Redemption Date, the Holders will have no further rights except to receive, upon surrender of the Warrant, the redemption
price. From and after the date specified for redemption, the Company will, at the place specified in the notice of redemption,
upon presentation and surrender to the Company by or on behalf of the holder of one or more Warrants to be redeemed, deliver or
cause to be delivered to or upon the written order of such holder a sum in cash equal to the redemption price of each such Warrant.
From and after the date fixed for redemption and upon the deposit or setting aside by the Company of a sum sufficient to redeem
all the Warrants called for redemption, such Warrants will expire and become void and all rights hereunder and under the Warrant
Certificates, except the right to receive payment of the redemption price, will cease.

 

(d) If
the shares of the Company’s Common Stock are subdivided or combined into a greater or smaller number of shares of Common
Stock, the Target Price will be proportionately adjusted by the ratio which the total number of shares of Common Stock outstanding
immediately prior to such event bears to the total number of shares of Common Stock to be outstanding immediately after such event.

 

6. Piggyback
Registration Rights. Whenever the Company shall propose to file a registration statement under the Securities Act on a form
which permits the inclusion of the Warrant Shares for resale (a “Qualifying Registration Statement”), it will give
written notice to the Holder at least 10 calendar days prior to the anticipated filing thereof, specifying the approximate date
on which the Company proposes to file the Qualifying Registration Statement and the intended method of distribution in connection
therewith, and advising the Holder of its right to have any or all of the Warrant Shares then held included among the securities
to be covered by such registration statement (the “Piggyback Rights”), subject to restrictions set forth herein:

 

(a) The
Holder shall have the right to include the Warrant Shares in one or more Qualifying Registration Statement until all of the Warrant
Shares have been sold, or until all of the Warrant Shares are eligible for sale under Rule 144 promulgated by the SEC or any similar
or successor rule, whichever shall first occur. In the event that the Holder elects to use the Piggyback Rights, the Company shall
include in the Qualifying Registration Statement the number of the Warrant Shares identified by the Holder in a written request
(the “Piggyback Request”) given to the Company not later than 10 calendar days prior to the proposed filing date of
the Qualifying Registration Statement.

 

(b) The
Warrant Shares identified in the Piggyback Request shall be included in the Qualifying Registration Statement on the same terms
and conditions as the other shares of Common Stock included in the Qualifying Registration Statement. Notwithstanding anything
in this Note to the contrary, the Holder shall not have Piggyback Rights with respect to: (i) a registration statement on Form
S-4 or any successor forms thereto; (ii) a registration statement on Form S-8 or any successor forms thereto; (iii) a registration
statement filed in connection with an exchange offer or an offering of securities solely to existing stockholders or employees
of the Company; or (iv) a registration statement filed in connection with an offering by the Company of securities convertible
into or exchangeable for Common Stock.

 

(c) Piggyback
rights are subject to cut back, on a pro-rata basis among Note holders, if the lead managing underwriter selected by the Company
for an underwritten offering for which Piggyback Rights are requested determines that marketing or other factors require a limitation
on the number of shares of Common Stock to be offered and sold in such offering or pursuant to Section 415 of the Securities Act,
as determined in good faith by the Company and its counsel.

 

    	 

    	 

    

 

(d) Nothing
contained in this Section shall create any liability on the part of the Company to the Holder if the Company for any reason should
decide not to file a Qualifying Registration Statement for which Piggyback Rights are available or to withdraw such Qualifying
Registration Statement subsequent to its filing, regardless of any action whatsoever that the Holder may have taken, whether as
a result of the issuance by the Company of any notice under this Note or otherwise.

 

7. Notices.
Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance
with the Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions taken pursuant to
this Warrant, including in reasonable detail a description of such action and the reason therefor.

 

8. Amendment
and Waiver. Any terms of the Warrants may be amended, modified or waived with, but only with, the written consent of the Company
and the Majority Holders (as defined in the Notes); provided, however, that no such waiver, amendment or modification
will reduce the aforesaid percentage in interest of the Notes the Holders of which are required to consent to any waiver, amendment
or modification; provided, further, that in the event that such waiver, amendment or modification adversely affects
the rights or obligations of a Holder in a different manner than the other Holders, such waiver, amendment or modification shall
also require the written consent of such differently affected Holder. Any amendment or waiver effected in accordance with this
Section will be binding upon the Company, the Holders and each transferee of the Warrants.

 

9. Severability.
If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent
jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the
broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect
the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without
material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity
or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations
of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will
endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s),
the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).

 

10. Governing
Law. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of Delaware without
giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of Delaware. Each of the Parties submits
to the jurisdiction of any state or federal court sitting in the State of Delaware, in any action or proceeding arising out of
or relating to this Agreement and agrees that all claims in respect of the action or proceeding may be heard and determined in
any such court. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted
by law. Nothing contained herein shall be deemed or operate to preclude the Holder from bringing suit or taking other legal action
against the Company in any other jurisdiction to collect on the Company’s obligations to the Holder or to enforce a judgment
or other court ruling in favor of the Holder.

 

    	 

    	 

    

 

11. Construction;
Headings. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against
any Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or
affect the interpretation of, this Warrant.

 

12. Dispute
Resolution. In the case of a dispute as to the determination of the Exercise Price, the Closing Sale Price, the Bid Price
or fair market value or the arithmetic calculation of the Warrant Shares (as the case may be), the Company or the Holder (as the
case may be) shall submit the disputed determinations or arithmetic calculations (as the case may be) via facsimile or email (i)
within two (2) Business Days after receipt of the applicable notice giving rise to such dispute to the Company or the Holder (as
the case may be) or (ii) if no notice gave rise to such dispute, at any time after the Holder learned of the circumstances giving
rise to such dispute. If the Holder and the Company are unable to agree upon such determination or calculation (as the case may
be) of the Exercise Price, the Closing Sale Price, the Bid Price or fair market value or the number of Warrant Shares (as the
case may be) within three (3) Business Days of such disputed determination or arithmetic calculation being submitted to the Company
or the Holder (as the case may be), then the Company shall, within two (2) Business Days submit via facsimile or email (a) the
disputed determination of the Exercise Price, the Closing Sale Price, the Bid Price or fair market value (as the case may be)
to an independent, reputable investment bank selected by the Holder or (b) the disputed arithmetic calculation of the Warrant
Shares to the Company’s independent, outside accountant. The Company shall cause at its expense the investment bank or the
accountant (as the case may be) to perform the determinations or calculations (as the case may be) and notify the Company and
the Holder of the results no later than ten (10) Business Days from the time it receives such disputed determinations or calculations
(as the case may be). Such investment bank’s or accountant’s determination or calculation (as the case may be) shall
be binding upon all parties absent demonstrable error. With regard to any conflict of methods for dispute resolution as described
in this paragraph compared to methods described in 1(a)(iii) above, the latter shall prevail and be the applicable method in that
circumstance.

 

13. Remedies,
Characterization, Other Obligations, Breaches and Injunctive Relief. The remedies provided in this Warrant shall be cumulative
and in addition to all other remedies available under this Warrant, the Notes and the Purchase Agreement at law or in equity (including
a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue
actual damages for any failure by the Company to comply with the terms of this Warrant. The Company covenants to the Holder that
there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided
for herein with respect to payments, exercises and the like (and the computation thereof) shall be the amounts to be received
by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance
thereof). The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder
and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such
breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available remedies, to an
injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being
required. The Company shall provide all information and documentation to the Holder that is requested by the Holder to enable
the Holder to confirm the Company’s compliance with the terms and conditions of this Warrant (including, without limitation,
compliance with Section 2 hereof). The issuance of shares and certificates for shares as contemplated hereby upon the exercise
of this Warrant shall be made without charge to the Holder or such shares for any issuance tax or other costs in respect thereof,
provided that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the
issuance and delivery of any certificate in a name other than the Holder or its agent on its behalf.

 

    	 

    	 

    

 

14. Transfer.
Neither the issuance and sale of the securities represented by this certificate nor the securities into which these securities
are exercisable have been registered under the Securities Act of 1933, as amended, or applicable state securities laws. The securities
may not be offered for sale, sold, transferred or assigned (i) in the absence of (a) an effective registration statement for the
securities under the Securities Act of 1933, as amended, or (b) an opinion of counsel to the Holder (if requested by the Company),
in a form reasonably acceptable to the Company, that registration is not required under said Act or (ii) unless sold or eligible
to be sold pursuant to Rule 144 or Rule 144a under said Act. Notwithstanding the foregoing, the securities may be pledged in connection
with a bona fide margin account or other loan or financing arrangement secured by the securities.

 

15. Certain
Definitions. For purposes of this Warrant, the following terms shall have the following meanings:

 

(a) “Common
Stock” means the common stock, $0.000001 par value per share, of the Company.

 

(b) “Convertible
Securities” means any stock or other security (other than Options) that is at any time and under any circumstances, directly
or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any
shares of Common Stock.

 

(c) “Expiration
Date” means the date that is the five (5) year anniversary of the Issuance Date or, if such date falls on a day other than
a Business Day or on which trading does not take place on the Principal Market (a “Holiday”), the next date that is
not a Holiday.

 

(d) “Options”
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.

 

    	 

    	 

    

 

(e) “Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.

 

(f) “Principal
Market” the principal securities exchange or trading market where the Common Stock is listed or traded as reported by Bloomberg.

 

(g) “Trading
Day” means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal
trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock
is then traded, provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade
on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final
hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading
on such exchange or market, then during the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated
as a Trading Day in writing by the Holder.

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the Issuance Date set out above.

 

	 	BARFRESH
    FOOD GROUP, Inc.
	 	 	 
	 	By:	 
	 	Name:	Joseph
    S. Tesoriero
	 	Title:	Chief
    Financial Officer

 

    	 

    	 

    

 

EXERCISE
NOTICE

 

BARFRESH
FOOD GROUP, Inc.

 

The
undersigned holder hereby exercises the right to purchase _________________ of the shares of Common Stock (“Warrant Shares”)
of Barfresh Food Group Inc., a Delaware corporation (the “Company”), evidenced by Warrant to Purchase Common Stock
No. _______ (the “Warrant”). Capitalized terms used herein and not otherwise defined shall have the respective meanings
set forth in the Warrant.

 

1. Payment
of Exercise Price. The Holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in
accordance with the terms of the Warrant.

 

2. Delivery
of Warrant Shares. The Company shall deliver to Holder, or its designee or agent as specified below, __________ Warrant Shares
in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, to the following address:

 

	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

IN
WITNESS WHEREOF, the undersigned has caused this notice to be duly executed as of the date set forth below.

 

	Date: 	 
	 	Registered
    Holder
	 	 
	 	By:	 
	 	Name:
	 	Title:

 

    	 

    	 

    

 

ACKNOWLEDGMENT

 

The
Company hereby acknowledges this Exercise Notice and hereby directs ______________ to issue the above indicated number of shares
of Common Stock in accordance with the Transfer Agent Instructions dated ______________, from the Company and acknowledged and
agreed to by _______________.

 

	Date:	BARFRESH
    FOOD GROUP, Inc.
	 	 	 
	 	By:	 
	 	Name:	Joseph
    S. Tesoriero
	 	Title:	Chief
    Financial Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}]]